230 A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.

229 Inhalation of peptide-loaded nanoparticles improves heart failure.

228 Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure.

227 Heart Repair Using Nanogel-Encapsulated Human Cardiac Stem Cells in Mice and Pigs with Myocardial Infarction.

226 Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis.

225 A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation.

224 Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.

223 Oxygen Therapy in Suspected Acute Myocardial Infarction.

222 Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.

221 Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

Free Images for Presentation: sunipix SUNIPIX